Arvinas, Inc. (ARVN) vs REGENXBIO Inc. (RGNX)
Arvinas, Inc. and REGENXBIO Inc. are both Biotechnology companies. Arvinas, Inc. and REGENXBIO Inc. are of similar size ($509.4M and $487.8M). REGENXBIO Inc. has negative trailing earnings, so its P/E is not meaningful; Arvinas, Inc. trades at 58.3×. REGENXBIO Inc. grew revenue faster over the last twelve months: 12.0% against −15.1%. Arvinas, Inc. has the higher net margin (2.94% vs −112.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Arvinas, Inc. leads on 14 and REGENXBIO Inc. on 3.
Valuation
Profitability
| Metric | ARVN | RGNX | Biotechnology median |
|---|---|---|---|
| Gross margin | 97.16% | 86.38% | 65.16% |
| Operating margin | (5.72%) | (94.08%) | 0.00% |
| Net margin | 2.94% | (112.58%) | 0.00% |
| Free cash flow margin | (65.93%) | (143.09%) | 0.00% |
| Return on equity | 1.59% | (137.63%) | (57.72%) |
| Return on assets | 1.17% | (40.60%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack